Table 2.

Baseline Cognitive Characteristics of Study Participants

	Overall	Non-drug group (C)	Other antihypertensive drug group (O)	ACE-I Users	Diuretic Users	AT2RB Users
3MS	93.4 ± 4.7	93.6 ± 4.7	93.1 ± 4.7	93.1 ± 4.4	93.4 ± 4.6	92.4 ± 4.8
TMT-A	43.7 ± 16.3	43.3 ± 16.1	44.0 ± 16.2	43.7 ± 14.5	44.6 ± 18.1	43.4 ± 17.2
TMT-B	110.7 ± 45.2	107.2 ± 43.8	113.5 ± 46.4	111 ± 42.4	116.6 ± 47.8	113.7 ± 50.1
CVLT-FRS	8.1 ± 3.2	8.2 ± 3.2	7.7 ± 3.2	7.9 ± 3.0	8.3 ± 3.1	8.2 ± 3.1
CVLT-FRL	8.8 ± 3.2	8.9 ± 3.3	8.4 ± 3.2	8.7 ± 3.3	9.2 ± 3.0	9.2 ± 2.9
CVLT-Sum	43.3 ± 10.5	43.7 ± 10.8	41.6 ± 10.1	42.2 ± 10.3	44.9 ± 9.7	43.6 ± 10.7
RO-IR	14.7 ± 4.3	14.9 ± 4.3	14.6 ± 4.1	14.6 ± 4.2	14.3 ± 4.2	14.2 ± 4.1
RO-DR	13.8 ± 4.3	14.0 ± 4.4	13.8 ± 4.1	13.8 ± 4.3	13.3 ± 4.2	13.7 ± 4.2
RO-Copy	20.0 ± 2.8	20.0 ± 2.8	20.0 ± 2.7	19.9 ± 2.8	20 ± 2.9	19.7 ± 2.5

Values listed are mean ± s.d.

ACE-I = Angiotensin Converting Enzyme Inhibitor, AT2RB = Angiotensin II Receptor Blocker.

3MS = Modified Mini Mental State Exam; TMT-A = Trail Making Test, Part A; TMT-B = Trail Making Test, Part B; CVLT = California Verbal Learning Test (CVLT-FRS = short delayed free recall; CVLT-FRL = long delayed free recall; CVLT-Sum = Sum of trials 1 to 5 of List A), RO = Rey-Osterrieth Complex Figure Test (RO-IR = immediate recall; RO-DR = delayed recall; RO-Copy =

Copy).